MIRA INFORM REPORT

 

 

Report Date :

07.02.2014

 

IDENTIFICATION DETAILS

 

Name :

NOVA PHARMA CO., LTD.

 

 

Registered Office :

114 Moo 2, T. Bangluang,  A. Muang, Pathumthani  12000, 

 

 

Country :

Thailand

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

29.06.2007

 

 

Com. Reg. No.:

0105550068094

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Subject is engaged  in  importing  and  distributing  various  kinds  of  human   pharmaceuticals  and  raw  chemicals  for  pharmaceutical  industry

 

 

No. of Employees :

19

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

Thailand

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

THAILAND - ECONOMIC OVERVIEW

 

With a well-developed infrastructure, a free-enterprise economy, generally pro-investment policies, and strong export industries, Thailand achieved steady growth due largely to industrial and agriculture exports - mostly electronics, agricultural commodities, automobiles and parts, and processed foods. Thailand is trying to maintain growth by encouraging domestic consumption and public investment to offset weak exports in 2012. Unemployment, at less than 1% of the labor force, stands as one of the lowest levels in the world, which puts upward pressure on wages in some industries. Thailand also attracts nearly 2.5 million migrant workers from neighboring countries. The Thai government is implementing a nation-wide 300 baht ($10) per day minimum wage policy and deploying new tax reforms designed to lower rates on middle-income earners. The Thai economy has weathered internal and external economic shocks in recent years. The global economic crisis severely cut Thailand's exports, with most sectors experiencing double-digit drops. In 2009, the economy contracted 2.3%. However, in 2010, Thailand's economy expanded 7.8%, its fastest pace since 1995, as exports rebounded. In late 2011 growth was interrupted by historic flooding in the industrial areas in Bangkok and its five surrounding provinces, crippling the manufacturing sector. Industry recovered from the second quarter of 2012 onward with GDP growth at 5.5% in 2012. The government has approved flood mitigation projects worth $11.7 billion, which were started in 2012, to prevent similar economic damage, and an additional $75 billion for infrastructure over the next seven years with a plan to start in 2013

 

Source : CIA

 

 

Company name and address

 

NOVA PHARMA  CO., LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           114  MOO  2,  T. BANGLUANG,  A. MUANG,

                                                                        PATHUMTHANI  12000,  THAILAND

TELEPHONE                                         :           [66]  2581-1892-3

FAX                                                      :           [66]  2581-1894

E-MAIL  ADDRESS                                :           -

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

ESTABLISHED                                     :           2007

REGISTRATION  NO.                           :           0105550068094

TAX  ID  NO.                                         :           3032689335

CAPITAL REGISTERED                         :           BHT.   27,000,000

CAPITAL PAID-UP                                :           BHT.   27,000,000

SHAREHOLDER’S  PROPORTION         :           THAI     :    100%

FISCAL YEAR CLOSING DATE              :           DECEMBER   31            

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MR.  PACHARA  POKAVIPANUN,  THAI

                                                                        MANAGING  DIRECTOR           

NO.  OF  STAFF                                   :           19

LINES  OF  BUSINESS                          :           HUMAN  PHARMACEUTICALS  AND  CHEMICALS

                                                                        IMPORTER  AND  DISTRUIBUTOR

           

 

CORPORATE PROFILE                        

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  FAIR  PERFORMANCE             

 

 

 

 


 

HISTORY

 

The  subject  was  established  on  June  29,  2007  as  a  private  limited  company  under  the  registered  name  NOVA  PHARMA  CO., LTD.,   by  Thai  groups,  with  the  business  objective  to  import  and  distribute  various  kinds  of  human  pharmaceuticals  and  chemicals  to  domestic  market.  It  currently  employs  19  staff.  

 

The  subject’s   registered  address  is  114  Moo 2,  T. Bangluang,  A. Muang,  Pathumthani  12000,  and  this  is  the  subject’s  current  operation  address.  

 

THE  BOARD  OF  DIRECTOR

 

     Name

 

Nationality

Age

 

 

 

 

Mr. Pachara  Pokavipanun

 

Thai

61

 

AUTHORIZED  PERSON

 

The  above  director  signs  on  behalf  of  the  subject  with  company’s  affixed.

 

MANAGEMENT

 

Mr. Pachara  Pokavipanun   is  the  Managing  Director.

He  is  Thai  nationality  with  the  age  of  61  years  old.  

 

BUSINESS  OPERATIONS

 

The  subject  is  engaged  in  importing  and  distributing  various  kinds  of  human   pharmaceuticals  and  raw  chemicals  for  pharmaceutical  industry.

 

PURCHASE

 

90%  of  the  products  is  imported  from  Republic  of  China,  India,  Italy  and  Germany,  the  remaining  10%  is  purchased  from  local  suppliers.

 

SALES 

 

100%  of  the  products  is  sold  locally  by  wholesale  to  traders,  manufacturers  and 

end-users  both  private  company  and  government  sector.

 

SUBSIDIARY  AND  AFFILIATED  COMPANY

 

The  subject  is  not  found  to  have  any  subsidiary  or  affiliated  company  here  in  Thailand.

 

 

LITIGATION

 

Bankruptcy  and  Receivership

 

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

 

There  are  no  legal  suits  filed  against   the  subject  for  the  past  two  years.

 

CREDIT  

 

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days.

Local  bills  are  paid  by  cash  or  on  the  credits  term  of  30-60  days.

Imports  are  by  T/T.

 

BANKING

 

Bangkok  Bank  Public  Co.,  Ltd.

 

EMPLOYMENT

 

The  subject  currently  employs  19  staff.  

 

LOCATION  DETAILS

 

The  premise  is  owned for  administrative  office  at  the  heading  address.  Premise  is  located  in  provincial, on  the  outskirts  of  Bangkok.

 

 

COMMENT

 

Pharmaceutical  consumption in  domestic  market  remains  strong,    Subject  was  formed  in 2007 as an importer  and  distributor  of  human  pharmaceuticals  and  chemicals.   Sales  were  moderate  in  the  past  several  years,  while  current  business  remains  healthy.

 

 

FINANCIAL INFORMATION

 

The  capital  was  registered at  Bht. 1,000,000  divided  into 10,000  shares  of  Bht.  100  each  with  fully  paid.

 

The  capital  was  increased  later  as  follows:

 

            Bht.  11,500,000  on       February  22,  2008

            Bht.  27,000,000  on       September  5,  2008

 

The  latest  registered  capital  was  increased  to  Bht. 27,000,000  divided  into  270,000  shares  of  Bht. 100  each  with  fully  paid.

 

THE  SHAREHOLDERS  LISTED  WERE  :  [as  at  April  30,  2013]

 

       NAME

HOLDING

%

 

 

 

Mr. Pachara  Pokavipanun

Nationality:  Thai

Address     :  The  Paradise  Village,  48/25  Moo  1, 

                     Thungsonghong,  Laksi,  Bangkok 

62,480

23.14

Mrs. Warunee  Mangmool

Nationality:  Thai

Address     :  102/7  Moo  6,  T. Bangkuwat,  A. Muang,

                     Pathumthani

55,500

20.56

Mr. Thanakorn  Pokavipanun

Nationality:  Thai

Address     :  102/7  Moo  6,  T. Bangkuwat,  A. Muang,

                     Pathumthani

54,760

20.28

Mr.  Schwin  Pokavipanun

Nationality:  Thai

Address     :  102/7  Moo  6,  T. Bangkuwat,  A. Muang,

                     Pathumthani

50,500

18.70

Mr. Charoonpong  Kiattiwong

Nationality:  Thai

Address     :  776/2-4 Ratchadapisek [Thaphra-Taksin] Rd.,

                      Daokanong,  Thonburi,  Bangkok

33,250

12.31

Ms. Rungnapa  Taesukhawat

Nationality:  Thai

Address     :  37/19  Moo  1,  Thungkru,  Bangkok

13,500

5.00

Ms. Worawan  Chansawang

Nationality:  Thai

Address     :  48/25  Moo  1,  Thungsonghong,  Laksi,

                     Bangkok

      10

0.01

 

Total  Shareholders  :    7

 

 

Share  Structure  [as  at  April  30,  2013]

 

Nationality

Shareholders

No. of  Share

% Shares

 

 

 

 

Thai

7

270,000

100.00

Foreign

-

-

-

 

Total

 

7

 

270,000

 

100.00

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC  ACCOUNTANT  NO. :

 

Mr. Thanont  Chaitawut  No.   6082

 


 

BALANCE SHEET [BAHT]

 

The  latest  financial figures  published  as  at  December  31,  2012,  2011  &  2010  were:

          

ASSETS

                                                                                                

Current Assets

2012

2011

2010

 

 

 

 

Cash  and Cash Equivalents     

7,513,400.37

8,345,949.51

15,903,552.76

Trade  Accounts  Receivable 

34,329,862.43

33,771,872.27

33,980,110.86

Inventories     

15,904,412.27

12,108,832.76

16,945,827.34

Other  Current  Assets                  

419,824.08

1,292,150.02

975,578.01

 

 

 

 

Total  Current  Assets                

58,167,499.15

55,518,804.56

67,805,068.97

 

 

 

 

Cash at Bank pledged as a Collateral

7,641,510.26

7,390,626.98

7,382,396.39

Fixed Assets

20,793,524.98

10,339,831.14

4,102,910.22

Other Non-current  Assets                       

279,030.00

117,000.00

117,000.00

 

Total  Assets                 

 

86,881,564.39

 

73,366,262.68

 

79,407,375.58

 

 

LIABILITIES & SHAREHOLDERS’ EQUITY [BAHT]

 

Current Liabilities

2012

2011

2010

 

 

 

 

Short-term Loan  from

  Financial Institutions

 

11,164,175.76

 

4,940,237.49

 

5,054,404.10

Trade  Accounts  Payable    

5,584,760.45

7,810,774.59

22,709,952.74

Current  Portion  of  Lease  Contract

   Liabilities

 

826,966.68

 

204,735.10

 

1,263,545.40

Current  Portion  of  Long-term  Loans

1,500,000.00

-

-

Short-term Loan from Related  Person 

7,625,169.66

6,582,862.46

353,976.52

Accrued  Expenses

2,129,100.49

2,434,717.02

1,352,085.93

Other  Current  Liabilities             

323,184.91

216,477.10

170,124.02

 

 

 

 

Total Current Liabilities

29,153,357.95

22,189,803.76

30,904,088.71

 

Lease  Contract  Liabilities, Net

 

1,057,019.36

 

-

 

82,651.75

Long-term Loan, Net

2,611,484.36

-

-

 

Total  Liabilities            

 

32,821,861.67

 

22,189,803.76

 

30,986,740.46

 

 

 

 

Shareholders' Equity

 

 

 

 

 

 

 

Share  capital : Baht  100  par  value 

  authorized,  issued  and  fully 

  paid  share  capital  270,000  shares

 

 

27,000,000.00

 

 

27,000,000.00

 

 

27,000,000.00

 

 

 

 

Capital Paid                       

27,000,000.00

27,000,000.00

27,000,000.00

Retained Earning  Unappropriated

  [Deficit]

 

27,059,702.72

 

24,176,458.92

 

21,420,635.12

 

Total  Shareholders' Equity

 

54,059,702.72

 

51,176,458.92

 

48,420,635.12

 

Total  Liabilities &  Shareholders' 

   Equity

 

 

86,881,564.39

 

 

73,366,262.68

 

 

79,407,375.58

 

 

PROFIT  &  LOSS  ACCOUNT

 

 

Revenue

2012

2011

2010

 

 

 

 

Sales  Income

89,185,388.27

92,764,385.97

93,396,868.15

Other  Income                 

1,267,525.30

895,772.63

1,977,309.44

 

Total  Revenues           

 

90,452,913.57

 

93,660,158.60

 

95,374,177.59

 

Expenses

 

 

 

 

 

 

 

Cost  of  Goods  Sold  

72,473,275.36

76,654,961.59

79,921,628.90

Selling  Expenses

3,818,160.55

3,803,961.23

4,042,401.02

Administrative  Expenses

9,685,223.30

8,821,774.44

9,057,191.45

 

Total Expenses             

 

85,976,659.21

 

89,280,697.26

 

93,021,221.37

 

 

 

 

Profit  before  Financial Cost

  &  Income  Tax

 

4,476,254.36

 

4,379,461.34

 

2,352,956.22

Financial  Cost

[548,351.44]

[379,717.73]

[274,532.42]

 

Profit  before  Income Tax

 

3,927,902.92

 

3,999,743.61

 

2,078,423.80

Income Tax

[1,044,659.12]

[1,243,919.81]

[881,824.87]

 

 

 

 

Net  Profit / [Loss]

2,883,243.80

2,755,823.80

1,196,598.93

 

 

FINANCIAL ANALYSIS

 

ITEM

UNIT

2012

2011

2010

 

 

 

 

 

LIQUIDITY RATIO

 

 

 

 

CURRENT RATIO

TIMES

2.00

2.50

2.19

QUICK RATIO

TIMES

1.44

1.90

1.61

 

 

 

 

 

ACTIVITY RATIO

 

 

 

 

FIXED ASSETS TURNOVER

TIMES

4.29

8.97

22.76

TOTAL ASSETS TURNOVER

TIMES

1.03

1.26

1.18

INVENTORY CONVERSION PERIOD

DAYS

80.10

57.66

77.39

INVENTORY TURNOVER

TIMES

4.56

6.33

4.72

RECEIVABLES CONVERSION PERIOD

DAYS

140.50

132.88

132.80

RECEIVABLES TURNOVER

TIMES

2.60

2.75

2.75

PAYABLES CONVERSION PERIOD

DAYS

28.13

37.19

103.72

CASH CONVERSION CYCLE

DAYS

192.47

153.35

106.47

 

 

 

 

 

PROFITABILITY RATIO

 

 

 

 

COST OF GOODS SOLD

%

81.26

82.63

85.57

SELLING & ADMINISTRATION

%

15.14

13.61

14.03

INTEREST

%

0.61

0.41

0.29

GROSS PROFIT MARGIN

%

20.16

18.33

16.55

NET PROFIT MARGIN BEFORE EX. ITEM

%

5.02

4.72

2.52

NET PROFIT MARGIN

%

3.23

2.97

1.28

RETURN ON EQUITY

%

5.33

5.38

2.47

RETURN ON ASSET

%

3.32

3.76

1.51

EARNING PER SHARE

BAHT

10.68

10.21

4.43

 

 

 

 

 

LEVERAGE RATIO

 

 

 

 

DEBT RATIO

TIMES

0.38

0.30

0.39

DEBT TO EQUITY RATIO

TIMES

0.61

0.43

0.64

TIME INTEREST EARNED

TIMES

8.16

11.53

8.57

 

 

 

 

 

ANNUAL GROWTH

 

 

 

 

SALES GROWTH

%

(3.86)

(0.68)

 

OPERATING PROFIT

%

2.21

86.13

 

NET PROFIT

%

4.62

130.30

 

FIXED ASSETS

%

101.10

152.01

 

TOTAL ASSETS

%

18.42

(7.61)

 

 

ANNUAL GROWTH : IMPRESSIVE

 

An annual sales growth is -3.86%. Turnover has decreased from THB 92,764,385.97 in 2011 to THB 89,185,388.27 in 2012. While net profit has increased from THB 2,755,823.80 in 2011 to THB 2,883,243.80 in 2012. And total assets has increased from THB 73,366,262.68 in 2011 to THB 86,881,564.39 in 2012.                  

                       

PROFITABILITY : RISKY

 

 

PROFITABILITY RATIO

 

Gross Profit Margin

20.16

Deteriorated

Industrial Average

107.80

Net Profit Margin

3.23

Satisfactory

Industrial Average

4.22

Return on Assets

3.32

Deteriorated

Industrial Average

6.89

Return on Equity

5.33

Deteriorated

Industrial Average

16.07

 

Gross Profit Margin used to assess a firm's financial health by revealing the proportion of money left over from revenues after accounting for the cost of goods sold. Gross profit margin serves as the source for paying additional expenses and future savings. The company's figure is 20.16%. When compared with the industry average, the ratio of the company was lower. This indicated that company may have problems with control over its costs.

 

Net Profit Margin is the indicator of the company's efficiency in that net profit takes into consideration all expenses of the company. A low profit margin indicates a low margin of safety, higher risk that a decline in sales will erase profits and result in a net loss. The company's figure is 3.23%. When compared with the industry average, the ratio of the company was lower.

 

Return on Assets measures how efficiently profits are being generated from the assets employed in the business when compared with the ratios of firms in a similar business. A low ratio in comparison with industry averages indicates an inefficient use of business assets. When compared with the industry average, it  was lower, the company's figure is 3.32%.

 

Return on Equity indicates how profitable a company is by comparing its net income to its average shareholders' equity, ROE measures how much the shareholders earned for their investment in the company. When compared with the industry average, it was lower, the company's figure is 5.33%.

 

Trend of the average competitors in the same industry for last 5 years

Return on Assets                       Uptrend

Return on Equity                        Uptrend

 

 

LIQUIDITY : ACCEPTABLE

 

 

LIQUIDITY RATIO

 

Current Ratio

2.00

Impressive

Industrial Average

1.63

Quick Ratio

1.44

 

 

 

Cash Conversion Cycle

192.47

 

 

 

 

The Current Ratio is to ascertain whether a company's short-term assets are readily available to pay off its short-term liabilities. The company's figure is 2.0 times in 2012, decreased from 2.5 times, then it is generally considered to have good short-term financial strength. When compared with the industry average, the ratio of the company was higher, indicated that company was an efficient operator in a dominant position within its industry.

 

The Quick Ratio is a liquidity indicator that further refines the current ratio by measuring the amount of the most liquid current assets there are to cover current liabilities. The company's figure is 1.44 times in 2012, decreased from 1.9 times, although excluding inventory so the company still have good short-term financial strength.

 

The Cash Conversion Cycle measures the number of days a company's cash is tied up in the production and sales process of its operations and the benefit from payment terms from its creditors. It meant the company could survive when no cash inflow was received from sale for 193 days.

 

Trend of the average competitors in the same industry for last 5 years

Current Ratio                 Uptrend

 

 

 

LEVERAGE : EXCELLENT

 


 

LEVERAGE RATIO

 

Debt Ratio

0.38

Impressive

Industrial Average

0.57

Debt to Equity Ratio

0.61

Impressive

Industrial Average

1.33

Times Interest Earned

8.16

Impressive

Industrial Average

-

 

Debt to Equity Ratio a measurement of how much suppliers, lenders, creditors and obligors have committed to the company versus what the shareholders have committed. A lower the percentage means that the company is using less leverage and has a stronger equity position.

 

Times Interest Earned measuring a company's ability to meet its debt obligations. Ratio is 8.17 higher than 1, so the company can pay interest expenses on outstanding debt.

 

Debt Ratio shows the proportion of a company's assets which are financed through debt. The company's figure is 0.38 less than 0.5, most of the company's assets are financed through equity.

 

Trend of the average competitors in the same industry for last 5 years

Debt Ratio                                 Uptrend

Times Interest Earned                Stable

 

ACTIVITY : IMPRESSIVE


 

ACTIVITY RATIO

 

Fixed Assets Turnover

4.29

Impressive

Industrial Average

-

Total Assets Turnover

1.03

Acceptable

Industrial Average

1.63

Inventory Conversion Period

80.10

 

 

 

Inventory Turnover

4.56

Impressive

Industrial Average

3.69

Receivables Conversion Period

140.50

 

 

 

Receivables Turnover

2.60

Impressive

Industrial Average

2.43

Payables Conversion Period

28.13

 

 

 

 

The company's Account Receivable Ratio is calculated as 2.60 and 2.75 in 2012 and 2011 respectively. This ratio measures the efficiency of the company in managing its trade debtors to generate revenue. A lower ratio may indicate over extension and collection problems. Conversely, a higher ratio may indicate an overtly stringent policy. In this case, the company's A/R ratio in 2012 decreased from 2011. This would suggest the company had deteriorated in the management of its debt collections.

 

Inventory Turnover in Days Ratio indicates the liquidity of inventory. It estimates the number of days that it will take to sell the current inventory. Inventory is particularly sensitive to change in business activities. The inventory turnover in days has increased from 58 days at the end of 2011 to 80 days at the end of 2012. This represents a negative trend. And Inventory turnover has decreased from 6.33 times in year 2011 to 4.56 times in year 2012.

 

The company's Total Asset Turnover is calculated as 1.03 times and 1.26 times in 2012 and 2011 respectively. This ratio is determined by dividing total assets into total sales turnover. The ratio measures the activity of the assets and the ability of the firm to generate sales through the use of the assets.

 

Trend of the average competitors in the same industry for last 5 years

Fixed Assets Turnover                Stable

Total Assets Turnover                 Uptrend

Inventory Turnover                      Uptrend

Receivables Turnover                  Uptrend

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.50

UK Pound

1

Rs.101.92

Euro

1

Rs.84.50

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIS

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.